FEAR & GREED | Business News Q+A: Why is Australia outperforming on biotech?
Aug 9, 2025
Stefan von Imhof, Co-founder and CEO of Alts.co, joins to discuss Australia's impressive performance in the biotech realm. He reveals how the country is leading in innovations like bioprinting human cells and cultured meat production. The conversation dives into the supportive environment for biotech firms and the cultural shifts needed for lab-grown food acceptance. With a focus on risk-taking and regulatory improvements, Stefan paints a hopeful picture of Australia's biotech future.
AI Snips
Chapters
Transcript
Episode notes
Exceptional Talent And Grant Support
- Australia has excellent universities, infrastructure and federal and state grants that help biotech firms get started.
- Stefan Von Imhof says this talent-plus-support lets Australia punch above its weight.
Mimicking Organs To Speed Cancer Research
- Inventure builds lab environments that mimic organs so scientists test cancers in realistic conditions.
- They sell these models to pharma to accelerate drug development.
Bioprinter Demonstration With Real Hand
- Stefan Von Imhof describes a tour where they placed a hand under a bioprinter that spat out a gel.
- The gel could fuse with skin and may replace skin grafting.